Saba NF - Search Results

1

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Docampo LCI, Haddad R, Rordorf T, Kiyota N, Tahara M, Lynch M, Jayaprakash V, Li L, Gillison ML. Ferris RL, et al. Among authors: saba nf. Oral Oncol. 2018 Jun;81:45-51. doi: 10.1016/j.oraloncology.2018.04.008. Epub 2018 Apr 17. Oral Oncol. 2018. PMID: 29884413 Free PMC article. Clinical Trial.

2

Moving toward bioadjuvant approaches to head and neck cancer prevention.

Saba NF, Hammond A, Shin DM, Khuri FR. Saba NF, et al. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S132-5. doi: 10.1016/j.ijrobp.2007.05.041. Int J Radiat Oncol Biol Phys. 2007. PMID: 17848282 Review.

3

Targeting angiogenesis in head and neck cancer.

Saba NF, Shin DM, Khuri FR. Saba NF, et al. Curr Cancer Drug Targets. 2007 Nov;7(7):643-9. doi: 10.2174/156800907782418356. Curr Cancer Drug Targets. 2007. PMID: 18045069 Review.

4

Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.

Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, Chen Z. Muller S, et al. Cancer. 2008 Jul 1;113(1):97-107. doi: 10.1002/cncr.23557. Cancer. 2008. PMID: 18473353 Free article.

5

Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.

Saba NF, Wang X, Müller S, Tighiouart M, Cho K, Nie S, Chen Z, Shin DM. Saba NF, et al. Head Neck. 2009 Apr;31(4):475-81. doi: 10.1002/hed.21003. Head Neck. 2009. PMID: 19072997 Free PMC article.

6

Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents.

Saba NF, Khuri FR. Saba NF, et al. Curr Opin Oncol. 2009 May;21(3):232-7. doi: 10.1097/cco.0b013e32832a56b3. Curr Opin Oncol. 2009. PMID: 19370807 Review.

7

Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.

Saba NF, Choi M, Muller S, Shin HJ, Tighiouart M, Papadimitrakopoulou VA, El-Naggar AK, Khuri FR, Chen ZG, Shin DM. Saba NF, et al. Cancer Prev Res (Phila). 2009 Sep;2(9):823-9. doi: 10.1158/1940-6207.CAPR-09-0077. Epub 2009 Sep 8. Cancer Prev Res (Phila). 2009. PMID: 19737986 Free PMC article.

8

ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.

Expert Panel on Radiation Oncology-Head and Neck; Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ. Expert Panel on Radiation Oncology-Head and Neck, et al. Oral Oncol. 2011 Jul;47(7):554-9. doi: 10.1016/j.oraloncology.2011.05.002. Epub 2011 Jun 12. Oral Oncol. 2011. PMID: 21664857 Review.

9

Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis.

Saba NF, Goodman M, Ward K, Flowers C, Ramalingam S, Owonikoko T, Chen A, Grist W, Wadsworth T, Beitler JJ, Khuri FR, Shin DM. Saba NF, et al. Oncology. 2011;81(1):12-20. doi: 10.1159/000330807. Epub 2011 Sep 8. Oncology. 2011. PMID: 21912193 Free PMC article.

10

Antiepidermal growth factor receptor therapy in squamous cell carcinoma of the head and neck.

Shaib W, Kono S, Saba N. Shaib W, et al. J Oncol. 2012;2012:521215. doi: 10.1155/2012/521215. Epub 2012 Jun 19. J Oncol. 2012. PMID: 22778735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page